January 13, 2026

Arcutis Biotherapeutics, Inc. (ARQT): Investor Outlook Reveals 18% Upside Potential

Arcutis Biotherapeutics, Inc. (NASDAQ: ARQT) is attracting significant attention in the biotechnology sector, with its robust pipeline of dermatology-focused treatments and a promising 18.09% upside based on analyst projections. Headquartered..

MoonLake Immunotherapeutics (MLTX): Navigating the Ups and Downs of a Volatile Biotech Stock

MoonLake Immunotherapeutics (NASDAQ: MLTX), a Swiss-based biotechnology company, is carving a niche in the healthcare sector with its innovative approach to treating inflammatory skin and joint diseases. Founded in 2021,..

Bausch Health Companies Inc. (BHC) Stock Analysis: Exploring the 563.16% ROE and Future Potential

Bausch Health Companies Inc. (NYSE: BHC) is a key player in the healthcare sector, operating within the drug manufacturers – specialty and generic industry. Headquartered in Laval, Canada, Bausch Health..

Recursion Pharmaceuticals, Inc. (RXRX) Stock Analysis: Potential Upside Amidst Biotechnology Challenges

Recursion Pharmaceuticals, Inc. (RXRX), a burgeoning name in the biotechnology sector, has piqued the interest of investors with its innovative approach to drug discovery, despite recent challenges reflected in its..

Tarsus Pharmaceuticals, Inc. (TARS) Stock Analysis: 15.85% Potential Upside with Strong Buy Ratings

Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS) has captured the attention of investors with its impressive growth potential and a robust product pipeline in the eye care sector. As a biopharmaceutical company..

SS Innovations International (SSII) Stock Analysis: Unpacking a 192.5% Revenue Surge in the Healthcare Device Sector

SS Innovations International, Inc. (SSII) is capturing attention in the healthcare sector with its remarkable 192.5% revenue growth, a standout figure in the medical devices industry. Headquartered in Gurugram, India,..

Merus N.V. (MRUS) Stock Analysis: Healthcare Innovator with 7.78% Upside Potential

Merus N.V. (NASDAQ: MRUS), a pioneering force in the biotechnology sector, is making waves with its innovative approach to immuno-oncology. Headquartered in Utrecht, the Netherlands, this clinical-stage company is dedicated..

Centessa Pharmaceuticals (CNTA) Stock Analysis: Expert Ratings Signal Robust 78.16% Upside Potential

Centessa Pharmaceuticals plc (NASDAQ: CNTA) is making waves in the biotech sector with its strong potential for growth, underscored by an impressive analyst rating. With a market capitalization of $3.25..

Zai Lab Limited (ZLAB) Stock Analysis: Potential 161% Upside Amid Strong Buy Consensus

Zai Lab Limited (NASDAQ: ZLAB) presents a compelling opportunity for investors seeking exposure to the rapidly evolving biotechnology sector. With a solid market capitalization of $2.04 billion, Zai Lab stands..

Biohaven Ltd. (BHVN) Investor Outlook: Navigating Opportunities with a 68% Upside Potential

Biohaven Ltd. (NASDAQ: BHVN), a prominent player in the biotechnology industry, has been capturing investor attention with its innovative approach in developing therapies across immunology, neuroscience, and oncology. With a..

Edgewise Therapeutics (EWTX) Stock Analysis: A 58% Upside Potential in the Biotech Sector

Edgewise Therapeutics, Inc. (NASDAQ: EWTX), a burgeoning player in the biotechnology industry, has captured investor attention with an enticing potential upside of 58.17%. This biopharmaceutical company, based in Boulder, Colorado,..

Organon & Co. (OGN) Stock Analysis: Exploring a 15% Potential Upside Amidst Diverse Product Portfolio

Organon & Co. (OGN), a prominent player in the healthcare sector, operates within the drug manufacturing industry, offering a wide range of health solutions through prescription therapies and medical devices...

Scholar Rock Holding Corporation (SRRK) Stock Analysis: A Biotech Innovator with a 13% Potential Upside

Scholar Rock Holding Corporation (NASDAQ: SRRK), a Cambridge-based biopharmaceutical company, is making headlines with its innovative approach in the biotechnology sector. Focusing on the discovery and development of novel therapies,..

Tandem Diabetes Care, Inc. (TNDM) Stock Analysis: Navigating a Path with a 20% Upside Potential

Tandem Diabetes Care, Inc. (TNDM) stands as a significant player in the healthcare sector, specifically within the medical devices industry. Headquartered in San Diego, California, Tandem Diabetes focuses on developing..

Sotera Health Company (SHC) Stock Analysis: Strong Buy Ratings and 7.68% Potential Upside

Sotera Health Company (NASDAQ: SHC) is drawing attention from investors with a strong buy consensus and a promising potential upside. As a leading player in the healthcare sector, particularly in..

CONMED Corporation (CNMD) Stock Analysis: A Look at Healthcare’s Undervalued Player with 11% Upside Potential

CONMED Corporation (NASDAQ: CNMD), a key player in the medical devices sector, stands as an intriguing prospect for investors seeking exposure in the healthcare industry. With a market capitalization of..

Envista Holdings Corporation (NVST) Stock Analysis: A Healthcare Player with a Mixed Growth Outlook

Envista Holdings Corporation (NYSE: NVST) is an intriguing entity in the healthcare sector, focusing on the medical instruments and supplies industry. As of the latest data, Envista boasts a market..

Guardian Pharmacy Services, Inc (GRDN) Stock Analysis: Evaluating a 10.28% Potential Upside for Investors

Guardian Pharmacy Services, Inc. (GRDN), a pivotal player in the healthcare sector, specifically within the medical care facilities industry, is capturing the attention of investors with its promising growth metrics..

Harmony Biosciences Holdings (HRMY) Stock Analysis: Strong Growth, Attractive Valuation, and Promising Upside

Harmony Biosciences Holdings, Inc. (NASDAQ: HRMY), a prominent player in the biotechnology sector, is catching the eye of investors with its robust growth trajectory and promising pipeline of neurological therapies...

GeneDx Holdings Corp. (WGS) Stock Analysis: Evaluating the 43.32% Potential Upside in the Genomic Sector

GeneDx Holdings Corp. (NASDAQ: WGS) stands at the intersection of cutting-edge genomics and diagnostics, carving a niche in the healthcare industry with its pioneering genetic testing services. As investors eye..

Search

Funds

January 13, 2026

Search

Funds

January 13, 2026

FTSE 100

Funds